
The episode discusses GLP-1, its effects, and an innovative oral alternative developed by Evolv, featuring insights from guest Becca McCarthy.
Everyone is talking about GLP-1s. But most people don't actually understand what GLP-1 is, where it came from, or why the injectable versions come with side effects like hair loss, muscle wasting, sunken face and mood flattening.I sat down with Becca McCarthy, co-founder of Evolv, a biotech company that has spent three years developing a patented oral GLP-1 peptide that mimics the same pathway as semaglutide and retatrutide without the injection, without the prescription and without those harsh side effects.We get into what GLP-1 actually is and why it is a hormone your body already makes, what food noise is and why silencing it changes your relationship with food entirely, why 97% of Americans are metabolically unhealthy and what that means for disease risk, how GLP-1 support helped Becca get through perimenopause when nothing else worked, why their 90-day clinical study is showing 12 pounds lost and 4 inches off the waist at the 8-week mark, how oral bioavailability works and why solving it is the biggest challenge in peptide science, why injectable GLP-1s can cause hair loss and what Evolv is doing differently, the connection between GLP-1s, sleep quality and chronic…
Host: Iman Hasan
Guest: Becca McCarthy
Organizations: Evolv
Products: GLP-1, semaglutide, retatrutide, BPC-157, GHK copper
Explore listener stats, chart rankings, contacts and more on the Biohack-it podcast page.